Posted by James
Only few cases of mucoceles were seen during the six-year study period. This confirms what has been documented in the literature concerning the rarity of these lesions in Nigerians and elsewhere. It has been observed that mucoceles, when encountered amongst Nigerians, usually present as a complication of chronic sinusitis. The little or no gender bias has also been confirmed by our study. However, from our study, more than half of our patients did not fall within the age bracket of 30-70 years reported in the literature; all cases except one isolated case of a one-year-old infant were >10 years of age. This may probable be due to the fact that the frontal sinus becomes well developed at age 7-8 years and full size at adulthood. The frontal sinus is also known to possess a complicated drainage pathway.
Read the rest of this entry »
Posted by James
This was a five-year retrospective review of cases of mucoceles of the paranasal air sinuses seen at the ENT department and referred to the eye clinic, both of the University College Hospital, Ibadan, Nigeria, between January 1998 and December 2003. Read the rest of this entry »
Posted by James
A total of 20 patients were involved in the study. These included nine (45%) males and 11 (55%) females with a male:female ratio of approximately 1:1. The mean age at presentation was 32.8 years, standard deviation 22.07 and range 1-75 years. The age and sex distribution of these patients is shown in Table 1. Mucoceles commonly involved more than one sinus on the same side. The sinuses commonly involved were the frontoethmoidal, frontal sinus and the maxillary sinuses. No bilateral case of mucocele was encountered in the study. Read the rest of this entry »
Posted by James
INTRODUCTION
Langenbeck first described mucoceles in the early 19th century, but their history certainly dates further back. Canalis described a third-century skull with changes in the frontal sinus skin to those that probably had mucocele. Until Roulette in 1896 coined the word mucocele, these lesions were known as hydatid cysts from the Greek word for a drop of water. The first description of mucocele, however, had been published1 in 1780 by Henry Nucalac.
Read the rest of this entry »
Posted by James
METHODS Over a one-month period, every other patient who attended the general medicine clinics at Grady Memorial Hospital was screened for the presence of CHD. The clinic was staffed by 140 interns and residents from the Emory University Internal Medicine Residency Program under the supervision of 40 general medicine Emory University attendings. Clinics were held daily with morning and afternoon clinic sessions. One-hundred-forty-seven patients with a clinical diagnosis of CHD were identified after excluding 35 CHD patients with dementia, terminal illness or cancer. Clinical and demographic data (age, gender and race) were collected on all patients by a single, trained chart reviewer. A documented diagnosis of CHD was defined by coronary disease proven by cardiac catheterization, a positive stress test or physician documentation of prior myocardial infarction. Read the rest of this entry »
Posted by James
Demographics One-hundred-forty-seven patients were identified as having CHD. The mean age of the patients was 66 ± 11 years, and 54.4% of the patients were women. The majority (91.8%) of the patients were African-American. Most patients were indigent and few had private insurance. The comorbidities of the patients are displayed in Table 1. In general, there was a high incidence of hypertension (99.3%), diabetes (46.2%) and heart failure (29.9%). Read the rest of this entry »
Posted by James
The frequency of lipid-lowering therapy (74.8%) in patients with CHD in this outpatient setting was relatively high but not as high as the frequency of patients on aspirin or antiplatelet therapy (88.4%). More than one-quarter of the patients in this cohort were not on any lipid-lowering therapy. In addition, only 55 patients (45.8%) were at a goal LDL <100 mg/dl. There was a significant proportion of patients that had LDL values from 100-129 mg/dl. At the time of this study, NCEP II provided the current practice guidelines. These recommendations called for an LDL <100 mg/dl for patients with known CHD and to consider drug therapy if LDL was greater than 130 mg/dl. NCEP III recommendations currently published have maintained an LDL goal <100 mg/dl with a consideration of drug therapy for those with LDL levels between 100-129 mg/dl.
Read the rest of this entry »
